PUREfi Wealth’s AbbVie ABBV Stock Holding History

PUREfi Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.1M	Sell	5,071 -993	-16%	-$220K	0.72%	31
2025 Q4	$1.39M	Buy	6,064 +36	+0.6%	+$8.2K	1.06%	22
2025 Q3	$1.4M	Buy	6,028 +199	+3%	+$40.5K	1.07%	19
2025 Q2	$1.08M	Buy	5,829 +878	+18%	+$163K	0.87%	27
2025 Q1	$1.04M	Buy	4,951 +1,995	+67%	+$388K	1.04%	17
2024 Q4	$525K	Buy	+2,956	New	+$543K	0.51%	49

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PUREfi Wealth's ABBV Position: Q1 2026 in Review

PUREfi Wealth reduced its AbbVie (ABBV) stake by 16% in Q1 2026, selling an estimated $220K and leaving 5,071 shares worth $1.1M. The position accounts for 0.72% of the portfolio, ranked #31.

PUREfi Wealth first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.4M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

PUREfi Wealth held 5,071 shares of AbbVie worth $1.1M as of Q1 2026.
PUREfi Wealth sold 993 AbbVie shares in Q1 2026, an estimated $220K.
AbbVie made up 0.72% of PUREfi Wealth's portfolio in Q1 2026, its #31 holding.
PUREfi Wealth first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
PUREfi Wealth's AbbVie position peaked at $1.4M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on PUREfi Wealth's 13F filing for Q1 2026, filed 28 Apr 2026.